Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.
about
Mitochondrial disorders in children: toward development of small-molecule treatment strategiesLeber hereditary optic neuropathy: current perspectivesDLK-1, SEK-3 and PMK-3 Are Required for the Life Extension Induced by Mitochondrial Bioenergetic Disruption in C. elegansA neurodegenerative perspective on mitochondrial optic neuropathiesIs there treatment for Leber hereditary optic neuropathy?A detailed analysis of methylmalonic acid kinetics during hemodialysis and after combined liver/kidney transplantation in a patient with mut (0) methylmalonic acidemiaTreatment strategies for inherited optic neuropathies: past, present and futureOxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.Treatment of mitochondrial disorders.Medical management of hereditary optic neuropathies.The optic nerve: a "mito-window" on mitochondrial neurodegenerationTrial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.The genetics of Leigh syndrome and its implications for clinical practice and risk managementSafety and effects of the vector for the Leber hereditary optic neuropathy gene therapy clinical trial.Nuclear expression of mitochondrial ND4 leads to the protein assembling in complex I and prevents optic atrophy and visual loss.Cell-permeable protein therapy for complex I dysfunctionNeuron-specific enolase is elevated in asymptomatic carriers of Leber's hereditary optic neuropathy.Mitochondrial disease: genetics and management.Efficacy and Safety of rAAV2-ND4 Treatment for Leber's Hereditary Optic NeuropathyThe elusive magic pill: finding effective therapies for mitochondrial disordersDrug development for rare mitochondrial disordersNew treatments for mitochondrial disease-no time to drop our standards.Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow-derived stem cells in the treatment of Leber's hereditary optic neuropathy.A rapid screening with direct sequencing from blood samples for the diagnosis of Leigh syndromeRetinal ganglion cell dysfunction in asymptomatic G11778A: Leber hereditary optic neuropathy.The clinical maze of mitochondrial neurologyExpert consensus document: Mitochondrial function as a therapeutic target in heart failureTreatment of hereditary optic neuropathies.Mitochondrial optic neuropathies: our travels from bench to bedside and back again.Novel therapeutic approaches for Leber's hereditary optic neuropathy.Genetic and phenotypic variability of optic neuropathies.Disturbed mitochondrial dynamics and neurodegenerative disorders.Emerging aspects of treatment in mitochondrial disorders.Leber Hereditary Optic Neuropathy: Bringing the Lab to the Clinic.Targeting estrogen receptor β as preventive therapeutic strategy for Leber's hereditary optic neuropathy.A Review of Mitochondrial Optic Neuropathies: From Inherited to Acquired FormsTherapeutic strategies for Leber's hereditary optic neuropathy: A current update.Therapeutic approaches for the treatment of Friedreich's ataxia.Glutathione as a Redox Biomarker in Mitochondrial Disease-Implications for Therapy.Pharmacological therapeutics in Friedreich ataxia: the present state.
P2860
Q26767327-1456F044-A552-4232-BD97-1F3523D04315Q26863599-8E88B752-C5C2-4691-B151-0C55765C9E12Q27308709-CE1D4EBB-79E6-43DD-9B79-028FFCBE5405Q28072026-4662942D-717E-480A-8641-2AF8C59B73FCQ28081486-EC1D3A28-2EBA-4999-A720-CAAFFEB83C48Q30407143-DC5F77BD-5C27-47B5-84BB-3C316B67B29CQ33595163-A44CE75A-39AE-45F7-AD20-155951BAAAE3Q33625254-9ABAE234-5ADB-4041-8D97-8DD16324DCFFQ33794684-C5FA37BE-4F76-4A43-9DB1-2748CD629B27Q33980183-15690F10-4518-46B1-9D31-50B5F8B7CA64Q34298350-55C9242A-FA0D-408F-A056-CF5EC9752293Q34404123-91960482-505D-44DD-BBD6-31F1A0006FC3Q34532004-21432EBF-4C99-4EB9-8E85-7399038BD04EQ34700126-6395D786-25C2-4E3C-B6BF-044DD98617D5Q35651068-1778B13E-25FD-496C-8908-A2003E37F37EQ35660914-9E85F22B-9685-427B-8C67-EEB224512AD5Q36257889-CA13029F-B21B-4339-A22B-1B384AB83DC6Q36492283-872382BC-66D6-4865-80E4-8CE63DC9F12FQ36595639-72898F52-F8D0-4088-8B28-012EFA1A68E5Q36762813-200E9ED8-BD73-415C-BB5E-3E90610F81BAQ36762826-26DD3B1A-DCCC-41A8-9998-2E6811194C5CQ37140299-D9F1E092-A596-4592-84D2-B848A0A96302Q37425269-0A6DB9F1-D420-483B-88E6-660C1336D71DQ37434032-F2A8A283-D4C5-40EF-99FC-C650EED945B4Q37577287-268CED37-2489-4F70-94EA-9E168A3A6164Q37648911-C15881ED-2E20-4640-BC7F-3FF8B6F382D7Q37699474-85945829-1E08-4BFF-84D7-C9A8B544FC51Q38040328-9C5321C0-A5E1-40E3-A03B-BF5B507B63BCQ38083877-2BC5914B-EB54-4874-9D3C-7EC8DD906D06Q38094802-39C3ED7A-AEA0-4778-97D1-13B17E161543Q38094807-41991E0E-4438-41F5-AFB1-722D6218A1EEQ38285228-CE20B523-82BC-483F-A1F8-6D11F0ED5B48Q38472989-4138AE74-E9BB-4482-98C2-967767A941C7Q38766836-BF149CE3-77A3-45B6-A7DE-69A0F80A2DA9Q38832079-FFCB275C-9243-4726-94B2-7115D995E284Q39063765-DD63BC0C-D864-4767-8A23-B67343AA5295Q39108502-31B0A4D0-21BA-4E69-95FE-3377528F1255Q39158402-17D85F6F-8ECF-45C9-B64D-A83A5C091E00Q39280494-1A1B56AD-5BFE-4532-8B25-B4992D74A64FQ39445743-2080FCA6-2F6B-44E6-9ECF-54AA97D10514
P2860
Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@en
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@nl
type
label
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@en
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@nl
prefLabel
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@en
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@nl
P2093
P1433
P1476
Effect of EPI-743 on the clini ...... r hereditary optic neuropathy.
@en
P2093
Alfredo A Sadun
Carlos Filipe Chicani
Fred N Ross-Cisneros
Guy Miller
Kenneth Kubis
Martin Thoolen
Piero Barboni
Valerio Carelli
William D Shrader
P304
P356
10.1001/ARCHNEUROL.2011.2972
P577
2012-03-01T00:00:00Z